MED21
Mediator of RNA polymerase II transcription subunit 21
Also known as: MED21_HUMAN, SRB7, SURB7
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13503
- Gene
- MED21
- Ensembl
- ENSG00000152944
- Chromosome
- 12
- Canonical length
- 144 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Cytosol
OverviewNCBI Gene
This gene encodes a member of the mediator complex subunit 21 family. The encoded protein interacts with the human RNA polymerase II holoenzyme and is involved in transcriptional regulation of RNA polymerase II transcribed genes. A pseudogene of this gene is located on chromosome 8. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2012]
Canonical amino-acid sequenceUniProt
144 residues, UniProt reviewed canonical sequence.
>Q13503|MED21
1 MADRLTQLQD AVNSLADQFC NAIGVLQQCG PPASFNNIQT AINKDQPANP TEEYAQLFAA
61 LIARTAKDID VLIDSLPSEE STAALQAASL YKLEEENHEA ATCLEDVVYR GDMLLEKIQS
121 ALADIAQSQL KTRSGTHSQS LPDSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MED21 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 33 nTPM
Expression across tissuesHPA
Tissue
- tongue: 33 nTPM
- testis: 28 nTPM
- bone marrow: 27 nTPM
- kidney: 24 nTPM
- parathyroid gland: 24 nTPM
- heart muscle: 24 nTPM
Single-cell type
- late primary spermatocytes: 308 nCPM
- early spermatids: 240 nCPM
- esophageal apical cells: 187 nCPM
- suprabasal keratinocytes: 157 nCPM
- esophageal suprabasal cells: 153 nCPM
- oocytes: 152 nCPM
Immune cell
- basophil: 56 nTPM
- naive CD4 T-cell: 35 nTPM
- T-reg: 35 nTPM
- eosinophil: 34 nTPM
- memory CD8 T-cell: 31 nTPM
- naive CD8 T-cell: 31 nTPM
Brain region
- cerebellum: 30 nTPM
- cerebral cortex: 27 nTPM
- hypothalamus: 24 nTPM
- choroid plexus: 24 nTPM
- basal ganglia: 24 nTPM
- hippocampal formation: 23 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.12
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.58
- DepMap mean gene effect
- -1.01
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- blastocyst development
- positive regulation of transcription by RNA polymerase II
- positive regulation of transcription elongation by RNA polymerase II
- positive regulation of transcription initiation by RNA polymerase II
- protein ubiquitination
- regulation of transcription by RNA polymerase II
- RNA polymerase II preinitiation complex assembly
- somatic stem cell population maintenance
Molecular functions
- DNA-directed RNA polymerase activity
- transcription coactivator activity
- transcription coregulator activity
- ubiquitin protein ligase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Mediator complex, subunit Med7/Med21-like
- Mediator complex, subunit Med21
- Subunit 21 of Mediator complex
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MED21 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MED21 as an antibody target. Whether an autoantibody or antibody against MED21 could matter depends on whether native MED21 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MED21 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MED21 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...